Home|Journals|Articles by Year Follow on Twitter

Directory for Medical Articles

Open Access

Original Research

Natl J Med Res. 2016; 6(2): 111-118

Skin advanced glycation end products (AGEs), RAGE and Glyoxalase-I (GLO-I) are associated with diabetic neuropathy in patients with type 1 diabetes.

Ahmed Alahmar, Ioannis Petropoulos, Maryam Ferdousi, Wendy Jones, Hassan Fadavi, Shazli Azmi, Uazman Alam, Omar Asghar, Aisha Meskiri, Ahmad Kheyami, Georgios Ponirakis, Andrew Marshall, Andrew J. M. Boulton, Mitra Tavakoli, Maria Jeziorska, Rayaz A. Malik.

Background: Advanced Glycation End Products (AGEs), their receptor (RAGE) and their detoxifying enzyme Glyoxalase-I (GLO-I) have been implicated in the development of experimental diabetic peripheral neuropathy (DPN). However, few studies have assessed their role in the tissues of diabetic patients.
Objective: To assess the relationship between skin expression of AGEs, RAGE, GLO-I and diabetic neuropathy in patients with type 1 diabetes.
Materials and methods: Sixty-two patients with type 1 diabetes mellitus (16 with and 46 without DPN) and 30 age-matched control subjects underwent detailed assessment of neurologic deficits, quantitative sensory testing, electrophysiology, corneal confocal microscopy (CCM) , intraepidermal nerve fiber density (IENFD) and AGEs, RAGE and GLO1-I expression in foot skin biopsies.
Results:Skin AGEs and RAGE expression was significantly higher and GLO-I was significantly lower in the epidermis, microvessels and reticular extracellular matrix of patients with diabetic neuropathy as compared to diabetic patients without neuropathy and control subjects. Skin AGEs and RAGE expression was also moderately but significantly increased and GLO-I expression was decreased in some skin structures in patients without diabetic neuropathy as compared to control subjects. Skin AGEs and RAGE expression correlated negatively and GLO-I expression correlated positively with sural nerve amplitude and velocity, IENFD and corneal nerve pathology.
Conclusion: These findings suggest that AGEs, RAGE and GLO-I may play an important role in the etiology of human diabetic neuropathy.

Key words: Diabetic neuropathy, Advanced glycation endproducts (AGEs), RAGE, Glyoxalase-I,

Similar Articles

Full-text options

Latest Statistics about COVID-19
• pubstat.org

Add your Article(s) to Indexes
• citeindex.org

Journal Finder
Covid-19 Trends and Statistics
Follow ScopeMed on Twitter
Online Journal Management
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright ScopeMed Information Services.